{"id":11626,"date":"2024-09-13T07:00:00","date_gmt":"2024-09-13T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/"},"modified":"2024-09-13T07:00:00","modified_gmt":"2024-09-13T05:00:00","slug":"irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/","title":{"rendered":"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference"},"content":{"rendered":"
\n

G\u00f6teborg, 13 september 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att bolaget kommer att ge en presentation vid Pareto Securities 15th Annual Healthcare Conference, i Stockholm den 19 september 2024.<\/strong><\/p>\n<\/div>\n

\n

Kristina Torfg\u00e5rd, VD, kommer att n\u00e4rvara och presentera IRLAB vid evenemanget, som arrangeras av Pareto Securities p\u00e5 Downtown Camper Scandic i Stockholm City.<\/p>\n

\u201dJag ser fram emot att tr\u00e4ffa nuvarande och nya potentiella investerare f\u00f6r att presentera v\u00e5r ledande portf\u00f6lj inom Parkinsons sjukdom och de framsteg vi g\u00f6r. Det \u00e4r en mycket sp\u00e4nnande tid f\u00f6r IRLAB just nu\u201d, s\u00e4ger Kristina Torfg\u00e5rd, VD.<\/p>\n

Mer information om eventet finns p\u00e5 Paretos webbsida:
https:\/\/paretosec.com\/updates\/events-and-conferences<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Kristina Torfg\u00e5rd, VD
Tel: +46 730 60 70 99
E-post: kristina.torfgard@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan st\u00f6rningar i hj\u00e4rnans signalsubstanser och hj\u00e4rnans sjukdomar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. IRL757, en substans som utvecklas f\u00f6r behandling av apati vid neurodegenerativa sjukdomar, befinner sig i Fas I. Dessutom utvecklar bolaget de tv\u00e5 prekliniska programmen IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg, 13 september 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att bolaget kommer att ge en presentation vid Pareto Securities 15th Annual Healthcare Conference, i Stockholm den 19 september 2024.<\/p>\n","protected":false},"template":"","class_list":["post-11626","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-presentation_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, 13 september 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att bolaget kommer att ge en presentation vid Pareto Securities 15th Annual Healthcare Conference, i Stockholm den 19 september 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/\",\"name\":\"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-09-13T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB","og_description":"G\u00f6teborg, 13 september 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att bolaget kommer att ge en presentation vid Pareto Securities 15th Annual Healthcare Conference, i Stockholm den 19 september 2024.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/","name":"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-09-13T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-pareto-securities-15th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB deltar p\u00e5 Pareto Securities 15th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}